Aug 17, 2026 · 6 min
European miners rise as drug trials reshape pharma stocks
Fresnillo AstraZeneca Climbs, Argenx Surges
The episode connects commodity prices, clinical-trial risk, and drone regulation to sharp moves across European and technology-linked companies.
- 1Fresnillo and other British mining stocks gained as copper and gold prices rose.
- 2AstraZeneca halted a lung cancer drug trial while Argenx shares surged on positive myositis-treatment results.
- 3DoorDash secured FAA approval to operate commercial delivery drones, targeting faster deliveries.
Don't miss
Argenx shares surge after positive trial results for its myositis treatment.
The brief
Stock Movers opens with European markets in focus as Louise Moon joins the report to explain why mining and pharmaceutical shares are moving.
British miners including Fresnillo benefited from rising copper and gold prices, showing how commodity markets can quickly redirect attention toward resource stocks.
Pharmaceutical news split sharply: AstraZeneca halted a lung cancer drug trial, while Argenx shares surged after positive results for a myositis treatment.
The closing tech segment turns to DoorDash, which gained FAA approval to operate commercial delivery drones as it seeks to cut delivery times.
Together, the episode tracks how commodity prices, clinical evidence, and regulatory approval can each become immediate catalysts for stock moves.
What was said on this episode
9 statements · 8 positive · 1 negative
Copper prices are approaching record highs.
“Copper is rising towards record highs.”
Listen at 1:14
Gold prices are rising.
“gold is also rising.”
Listen at 1:26
Mining companies are performing strongly overall.
“So overall strong performance for miners”
Listen at 1:39
AstraZeneca is stopping a trial of an experimental cancer drug.
“they're stopping a trial of a experimental cat cancer drug.”
Listen at 1:58
AstraZeneca reported positive late-stage studies for an approved lung-cancer drug.
“positive late late stage studies for an already approved drug to do also with lung cancer.”
Listen at 2:40
Argenx shares rose by as much as 10%.
“shares up as much as 10%.”
Listen at 3:00
Argenx reported a large, successful trial for its blockbuster drug.
“it reported its latest large and successful trial for its blockbuster drug.”
Listen at 3:02
DoorDash is building its own delivery drones.
“DoorDash, the largest food delivery company in the U.S. is building its own delivery drones”
Listen at 4:03
DoorDash drones can reduce delivery times for remote-location orders.
“Drones are also a way for DoorDash to cut delivery times on orders from more remote locations”
Listen at 4:38
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Featuring
United Kingdom
YouTubeListen to the full episode and explore every guest, topic, and moment on PodLume.